Adnan YALÇINKAYA, Seyhan YILMAZ, Taner SARAK, Volkan ÇAMKIRAN, Kerim ÇAĞLI, Adem İlkay DİKEN

The reliability of magnetic resonance imaging in patients undergoing cardiologic and cardiovascular surgical interventions

Manyetik rezonans görüntüleme klinik uygulamada giderek daha sık kullanılan değerli bir tanı aracıdır. Ancak, bu görüntüleme tekniğinin kullanımı, komplikasyon oranını artırdığı için, daha önceki kardiyolojik veya kardiyovasküler cerrahi girişimler sırasında metalik implant takılan hastalarda sınırlı olabilir. Teknolojik gelişmeler sayesinde bu tür cihazlar ve manyetik rezonans görüntüleme arasındaki geçimlilik oranı artmakla birlikte, beklenmedik sonuçlar ile birlikte etkileşim riski halen birçok olguda yüksektir. Bu yazıda, kanıta dayalı veriler eşliğinde, bu hasta popülasyonunda klinik uygulamada manyetik rezonans görüntülemenin güvenirliğine ilişkin pratik bir bilgi kaynağı ve rehber sunuldu.

Kardiyolojik ve kardiyovasküler cerrahi girişim yapılan hastalarda manyetik rezonans görüntülemenin güvenirliği

Magnetic resonance imaging is an invaluable diagnostic tool which is increasingly more frequently used in clinical practice. However, the utility of this imaging technique may be limited in patients with metallic implants placed during previous cardiologic or cardiovascular surgical interventions due to increased complication rates. Despite increased rates of compatibility between such devices and magnetic resonance imaging thanks to technological advances, the risk of interaction with untoward consequences is still high in many cases. Herein, we describe a practical source of information and guidance on the reliability of magnetic resonance imaging in this patient population in the clinical practice in the light of evidence-based data.

PDF

___

Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336-46.
Götte MJ, Rüssel IK, de Roest GJ, Germans T, Veldkamp RF, Knaapen P, et al. Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective. Neth Heart J 2010;18:31-7.
Tzifa A, Krombach GA, Krämer N, Krüger S, Schütte A, von Walter M, et al. Magnetic resonance-guided cardiac interventions using magnetic resonance-compatible devices: a preclinical study and first-in-man congenital interventions. Circ Cardiovasc Interv 2010;3:585-92.
Roguin A, Goldsher D. Magnetic resonance imaging and implantable cardiac electronic devices: it's not what we can do, it's what we should do. Isr Med Assoc J 2010;12:436-8.
Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326-8.
Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Etheridge S, et al. American College of Radiology White Paper on MR Safety: 2004 update and revisions. AJR Am J Roentgenol 2004;182:1111-4.
Faris OP, Shein M. Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 2006;114:1232-3.
Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007;116:2878-91.
Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315-24.
Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable- cardioverter defibrillators at 1.5 tesla. Circulation 2006;114:1277-84.
Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006;114:1285-92.
Giroletti E, Corbucci G. Cardiac magnetic resonance imaging: patient safety considerations. Phys Med 2005;21:5-13.
Shellock FG. Reference manual for magnetic resonance safety, implants, and devices: 2006 edition. Los Angeles, CA: Biomedical Research Publishing Group; 2006.
Bock M, Mohrs OK, Voigtlaender T, Kauczor HU, Semmler W. MRI safety aspects and artifacts of atrial septal defect and patent foramen ovale occluders at 1.5 tesla: a phantom study. Rofo 2006;178:272-7. [Abstract]
Shellock FG, Morisoli SM. Ex vivo evaluation of ferromagnetism and artifacts of cardiac occluders exposed to a 1.5-T MR system. J Magn Reson Imaging 1994;4:213-5.
Shellock FG, Valencerina S. Septal repair implants: evaluation of magnetic resonance imaging safety at 3 T. Magn Reson Imaging 2005;23:1021-5.
Hartnell GG, Spence L, Hughes LA, Cohen MC, Saouaf R, Buff B. Safety of MR imaging in patients who have retained metallic materials after cardiac surgery. AJR Am J Roentgenol 1997;168:1157-9.
Shellock FG, Morisoli S, Kanal E. MR procedures and biomedical implants, materials, and devices: 1993 update. Radiology 1993;189:587-99.
Baikoussis NG, Apostolakis E, Papakonstantinou NA, Sarantitis I, Dougenis D. Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. Ann Thorac Surg 2011;91:2006-11.
Hanedan MO, Yaşar E, Diken Aİ, Kadiroğulları E, Yalçınkaya A, Mola S, et al. İzole koroner arter baypas graft cerrahisi sonrası geçici pace telleri gerekli midir? Turk Gogus Kalp Dama 2012;20:488-91.
Higgins JV, Gard JJ, Sheldon SH, Espinosa RE, Wood CP, Felmlee JP, et al. Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol 2014;37:1284-90.
Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997;134:467-73.
Eggebrecht H, Zenge M, Ladd ME, Erbel R, Quick HH. In vitro evaluation of current thoracic aortic stent-grafts for real- time MR-guided placement. J Endovasc Ther 2006;13:62-71.
Hiramoto JS, Reilly LM, Schneider DB, Skorobogaty H, Rapp J, Chuter TA. The effect of magnetic resonance imaging on stainless-steel Z-stent-based abdominal aortic prosthesis. J Vasc Surg 2007;45:472-4.
Gawenda M, Gossmann A, Krüger K, Zaehringer M, Hahn M, Wassmer G, et al. Comparison of magnetic resonance imaging and computed tomography of 8 aortic stent-graft models. J Endovasc Ther 2004;11:627-34.
Duru F, Luechinger R, Scheidegger MB, Lüscher TF, Boesiger P, Candinas R. Pacing in magnetic resonance imaging environment: clinical and technical considerations on compatibility. Eur Heart J 2001;22:113-24.
Shellock FG. Prosthetic heart valves and annuloplasty rings: assessment of magnetic field interactions, heating, and artifacts at 1.5 Tesla. J Cardiovasc Magn Reson 2001;3:317-24.
Edwards MB, Ordidge RJ, Hand JW, Taylor KM, Young IR. Assessment of magnetic field (4.7 T) induced forces on prosthetic heart valves and annuloplasty rings. J Magn Reson Imaging 2005;22:311-7.
Edwards MB, Taylor KM, Shellock FG. Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5 T. J Magn Reson Imaging 2000;12:363-9.
Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004;232:635-52.
Shellock FG. Magnetic resonance safety update 2002: implants and devices. J Magn Reson Imaging 2002;16:485-96.
Shellock FG. Biomedical implants and devices: assessment of magnetic field interactions with a 3.0-Tesla MR system. J Magn Reson Imaging 2002;16:721-32.
Randall PA, Kohman LJ, Scalzetti EM, Szeverenyi NM, Panicek DM. Magnetic resonance imaging of prosthetic cardiac valves in vitro and in vivo. Am J Cardiol 1988;62:973-6.
Pruefer D, Kalden P, Schreiber W, Dahm M, Buerke M, Thelen M, et al. In vitro investigation of prosthetic heart valves in magnetic resonance imaging: evaluation of potential hazards. J Heart Valve Dis 2001;10:410-4.
Condon B, Hadley DM. Potential MR hazard to patients with metallic heart valves: the Lenz effect. J Magn Reson Imaging 2000;12:171-6.
Hashemi A, Alizadehasl A. New onset significant paravalvular leakage in a patient with mechanical prosthetic aortic valve after exposure to magnetic resonance imaging. Is There Any Relevance? Archives of Cardiovascular Imaging 2013;1:38-9.
van Gorp MJ, de Mol BA, Bakker CJ, van der Graaf Y, Mali WP. Black holes on MR images of the brain of patients with Björk-Shiley heart valves: additional observation in three cases. AJNR Am J Neuroradiol 2003;24:512-4.
Shellock FG, Forder JR. Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla. J Cardiovasc Magn Reson 2005;7:415-9.
Shellock FG. MR safety at 3-Tesla and coronary artery stents. MRIsafety.com. MRI safety, bioeffects and patient management [Internet]. 2008 [cited 2008 April 23]. Available from: http://www.mrisafety.com/safety_article. asp?subject=23
Shellock FG. MR safety at 3T: bare metal and drug eluting coronary artery stents. SIGNALS 2005;53:26-7.
Tejedor-Viñuela P, San Román-Calvar JA, Durán-Hernández JM, Gómez-Salvador I, Sierra-Román J, Fernández-Avilés F. Safety of early cardiac magnetic resonance imaging in acute myocardial infarction patients with stents. Rev Esp Cardiol 2006;59:1261-7. [Abstract]
Jehl J, Comte A, Aubry S, Meneveau N, Schiele F, Kastler B. Clinical safety of cardiac magnetic resonance imaging at 3 T early after stent placement for acute myocardial infarction. Eur Radiol 2009;19:2913-8.
Shellock FG, Shellock VJ. Cardiovascular catheters and accessories: ex vivo testing of ferromagnetism, heating,Depart and artifacts associated with MRI. J Magn Reson Imaging 1998;8:1338-42.
Dempsey MF, Condon B. Thermal injuries associated with MRI. Clin Radiol 2001;56:457-65.
Dempsey MF, Condon B, Hadley DM. Investigation of the factors responsible for burns during MRI. J Magn Reson Imaging 2001;13:627-31.
ECRI Institute. Health devices alert: a new MRI complication? May 27, 1988.
MRI safety. Institute for Magnetic Resonance Safety, Education, and Research. Available from: http://www. mrisafety.com. [Accessed: June 19, 2006].
Demir S, Yüksel S, Sahin M. Safety of magnetic resonance imaging in patients with implanted cardiovascular devices. [Article in Turkish] Turk Kardiyol Dern Ars 2008;36:485-96.
Prasad SK, Pennell DJ. Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices. Heart 2004;90:1241-4.
Shellock FG, Tkach JA, Ruggieri PM, Masaryk TJ. Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional ("long-bore") and "short-bore" 1.5- and 3.0-Tesla MR systems. J Cardiovasc Magn Reson 2003;5:387-97.
Hayes DL, Holmes DR Jr, Gray JE. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implanted peDepartDepartDepartrmanent pacemakers. J Am Coll Cardiol 1987;10:782-6.
Smith JM. Industry viewpoint: Guidant: Pacemakers, ICDs, and MRI. Pacing Clin Electrophysiol 2005;28:264.
Stanton MS. Industry viewpoint: Medtronic: Pacemakers, ICDs, and MRI. Pacing Clin Electrophysiol 2005;28:26Depart5.
Levine PA. Industry viewpoint: St. Jude Medical: Pacemakers, ICDs and MRI. Pacing Clin Electrophysiol 2005;28:266-7.
Faris OP, Shein MJ. Government viewpoint: U.S. Food & Drug Administration: Pacemakers, ICDs and MRI. Pacing Clin Electrophysiol 2005;28:268-9.
Irnich W, Irnich B, Bartsch C, Stertmann WA, Gufler H, Weiler G. Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005;7:353-65.
Food and Drug Administration, Center for Devices and Radiological Health. Medical device reporting. Available at: http://www.fda.gov/ cdrh/mdr/. [Accessed: December 1, 2006].
Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315-24.
Gimbel JR. Implantable pacemaker and defibrillator safety in the MR environment: new thoughts for the new millennium. In: 2001 Syllabus, Special Cross-Specialty Categorical Course in Diagnostic Radiology: Practical MR Safety Considerations for Physicians, Physicists, and Technologists. Oak Lawn, IL: Radiological Society of North America; 2001. p. 69-76.
Avery JK. Loss Prevention case of the month. Not my responsibility J Tenn Med Assoc 1988;81:523.
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34:2281-329.
Kodali S, Baher A, Shah D. Safety of MRIs in patients with pacemakers and defibrillators. Methodist Debakey Cardiovasc J 2013;9:137-41.
Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006;114:1285-92.
Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 2010;12:947-51.
Gimbel JR. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. Pacing Clin Electrophysiol 2008;31:795-801.
Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011;155:415-24.
Klima U, Beilner J, Bagaev E, Fischer S, Kofidis T, Lotz J. MRI-based safety evaluation of the ventrica magnetic coronary anastomotic system. Asian Cardiovasc Thorac Ann 2007;15:24-9.
Salzberg SP, Gillinov AM, DepartAnyanwu A, Castillo J, Filsoufi F, Adams DH. Surgical left atrial appendage occlusion: evaluation of a novel device with magnetic resonance imaging. Eur J Cardiothorac Surg 2008;34:766-70.